[1]
2026. Initial Evaluation of Dihydroartemisinin (DHA), Metformin and Taro Extract in Combination with Cisplatin for Enhanced Cytotoxicity in Triple-Negative Breast Cancer (TNBC) Cell Lines. Journal of Analytical Oncology. 15, (Jun. 2026), 53–57. DOI:https://doi.org/10.30683/1927-7229.2026.15.06.